Effects of Technology-Assisted Rehabilitation on Pain and Hand Function in People With Carpal Tunnel Syndrome
TECH-CTS-REHAB
Effects of a Technology-Assisted Multimodal Rehabilitation Program on Pain, Hand Function, Grip Strength, and Hand-Related Quality of Life in Individuals With Carpal Tunnel Syndrome
1 other identifier
interventional
40
1 country
1
Brief Summary
Carpal tunnel syndrome (CTS) is a common condition caused by compression of the median nerve at the wrist. It may cause pain, numbness, tingling, reduced hand function, decreased grip strength, and impaired quality of life. This randomized controlled trial compared the effects of a technology-assisted multimodal rehabilitation program with conventional physiotherapy in adults with mild-to-moderate carpal tunnel syndrome. A total of 40 participants were randomly allocated to two groups. The technology-assisted rehabilitation group used the ErgoActive system with Leap Motion sensor technology, while the conventional physiotherapy group received conventional physiotherapy. Both groups received 18 treatment sessions over six weeks. The primary outcome was symptom severity, assessed using the Symptom Severity Scale of the Boston Carpal Tunnel Questionnaire (BCTQ-SSS). Secondary outcomes included pain intensity, functional status, hand-related quality of life, and grip strength. Pain was assessed using a visual analogue scale (VAS), functional status using the Functional Status Scale of the Boston Carpal Tunnel Questionnaire (BCTQ-FSS), hand-related quality of life using the Michigan Hand Outcomes Questionnaire (MHQ), and grip strength using a grip strength measurement device. All outcomes were assessed before and after the treatment period. The study aimed to determine whether technology-assisted multimodal rehabilitation provides greater improvements in symptoms, pain, hand function, grip strength, and hand-related quality of life than conventional physiotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
October 13, 2026
CompletedFirst Posted
Study publicly available on registry
October 21, 2026
CompletedOctober 21, 2026
October 1, 2026
9 months
October 13, 2026
October 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptom Severity Assessed Using the Boston Carpal Tunnel Questionnaire (BCTQ-SSS)
The Symptom Severity Scale of the Boston Carpal Tunnel Questionnaire (BCTQ-SSS) was used to assess the severity of carpal tunnel syndrome symptoms. The measure was assessed at baseline and after completion of the six-week intervention period.
Baseline to immediately after the 6-week intervention period
Study Arms (2)
Technology-Assisted Multimodal Rehabilitation Group (TARG)
EXPERIMENTALParticipants in this group received a technology-assisted multimodal rehabilitation program using the ErgoActive system with Leap Motion sensor technology. The intervention consisted of 18 sessions delivered over six weeks for individuals with mild-to-moderate carpal tunnel syndrome. Outcomes were assessed at baseline and after completion of the intervention.
Conventional Physiotherapy Group (CPG)
ACTIVE COMPARATORParticipants in this group received conventional physiotherapy for mild-to-moderate carpal tunnel syndrome. The intervention consisted of 18 treatment sessions over six weeks. Outcomes were assessed at baseline and after completion of the intervention period. The results of this group were compared with those of the technology-assisted multimodal rehabilitation group.
Interventions
Participants assigned to the conventional physiotherapy group received conventional physiotherapy for mild-to-moderate carpal tunnel syndrome. The intervention consisted of 18 sessions delivered over six weeks. Outcomes were assessed before and after the intervention.
Participants assigned to the technology-assisted rehabilitation group received a multimodal rehabilitation program using the ErgoActive system with Leap Motion sensor technology for individuals with mild-to-moderate carpal tunnel syndrome. The intervention consisted of 18 sessions delivered over six weeks. Outcomes were assessed before and after the intervention.
Eligibility Criteria
You may qualify if:
- Individuals aged 35-55 years diagnosed with mild to moderate Carpal Tunnel Syndrome (CTS) at Rami Hospital who are able to engage with the Ergo Active rehabilitation system using Leap Motion sensors and artificial intelligence-based applications.
- Medically and clinically stable at the time of assessment and Ability to understand and follow verbal instructions and perform guided ergonomics exercises using the Ergo Active system.
- Willingness to participate in the study and provide written informed consent
You may not qualify if:
- Inability to comply with the study protocol due to cognitive, visual, or physical limitations.
- Severe Carpal Tunnel Syndrome symptoms VAS scale more than 8 in last 6 months or any neurological or musculoskeletal disorders affecting the upper limbs
- Prior surgical intervention for CTS less than 5 years or concurrent participation in any other rehabilitation program during the study period.
- Presence of systemic diseases, such as uncontrolled diabetes mellitus or thyroid dysfunction, that could influence the study outcomes.
- Pregnancy or lactation, which may alter nerve conduction and affect study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Rami Hospital
Istanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
October 13, 2026
First Posted
October 21, 2026
Study Start
May 15, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
October 21, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly to protect participant privacy and confidentiality. The study data will be handled in accordance with applicable ethical requirements and data protection regulations.